Skip to main content

Table 3 Independent predictors of all-cause mortality at 20 years in the sub group with baseline TG ≥200 mg/dL

From: Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial

  HR 95 % CI P value
Lower Upper
Fibrate treatment 0.75 0.60 0.94 0.012
Past MI 1.53 1.15 2.00 0.004
Glucose 1.00 0.99 1.01 0.12
Age (per year increment) 1.08 1.07 1.11 <0.001
BMI (per unit) 1.01 0.98 1.05 0.39
NYHA functional class ≥ II 1.09 0.89 1.33 0.41
HDL-C (per 1 mg/dl) 1.00 0.97 1.02 0.76
Diabetes mellitus 1.88 1.36 2.61 <0.001
  1. Model further adjusted for hypertension, gender and non-study lipid lowering medication as a time dependent covariate (all p > 0.05)